Literature DB >> 9405357

A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.

F Fazioli1, M Resnati, N Sidenius, Y Higashimoto, E Appella, F Blasi.   

Abstract

The role of urokinase-type plasminogen activator (uPA) and its receptor (uPAR/CD87) in cell migration and invasion is well substantiated. Recently, uPA has been shown to be essential in cell migration, since uPA-/- mice are greatly impaired in inflammatory cell recruitment. We have shown previously that the uPA-induced chemotaxis requires interaction with and modification of uPAR/CD87, which is the true chemoattracting molecule acting through an unidentified cell surface component which mediates this cell surface chemokine activity. By expressing and testing several uPAR/CD87 variants, we have located and functionally characterized a potent uPAR/CD87 epitope that mimics the effects of the uPA-uPAR interaction. The chemotactic activity lies in the region linking domains 1 and 2, the only protease-sensitive region of uPAR/CD87, efficiently cleaved by uPA at physiological concentrations. Synthetic peptides carrying this epitope promote chemotaxis and activate p56/p59(hck) tyrosine kinase. Both chemotaxis and kinase activation are pertussis toxin sensitive, involving a Gi/o protein in the pathway.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405357      PMCID: PMC1170328          DOI: 10.1093/emboj/16.24.7279

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

1.  Mutants of pertussis toxin suitable for vaccine development.

Authors:  M Pizza; A Covacci; A Bartoloni; M Perugini; L Nencioni; M T De Magistris; L Villa; D Nucci; R Manetti; M Bugnoli
Journal:  Science       Date:  1989-10-27       Impact factor: 47.728

2.  A soluble, ligand binding mutant of the human urokinase plasminogen activator receptor.

Authors:  M T Masucci; N Pedersen; F Blasi
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

3.  Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells.

Authors:  G Fibbi; M Ziche; L Morbidelli; L Magnelli; M Del Rosso
Journal:  Exp Cell Res       Date:  1988-12       Impact factor: 3.905

4.  Characterization of the cellular binding site for the urokinase-type plasminogen activator.

Authors:  A Estreicher; A Wohlwend; D Belin; W D Schleuning; J D Vassalli
Journal:  J Biol Chem       Date:  1989-01-15       Impact factor: 5.157

5.  Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.

Authors:  M Ploug; E Rønne; N Behrendt; A L Jensen; F Blasi; K Danø
Journal:  J Biol Chem       Date:  1991-01-25       Impact factor: 5.157

6.  Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain.

Authors:  G Høyer-Hansen; E Rønne; H Solberg; N Behrendt; M Ploug; L R Lund; V Ellis; K Danø
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

7.  Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma.

Authors:  C Pyke; N Graem; E Ralfkiaer; E Rønne; G Høyer-Hansen; N Brünner; K Danø
Journal:  Cancer Res       Date:  1993-04-15       Impact factor: 12.701

8.  Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas.

Authors:  C Pyke; P Kristensen; E Ralfkiaer; J Grøndahl-Hansen; J Eriksen; F Blasi; K Danø
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

9.  The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator.

Authors:  N Behrendt; M Ploug; L Patthy; G Houen; F Blasi; K Danø
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

10.  Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.

Authors:  A L Roldan; M V Cubellis; M T Masucci; N Behrendt; L R Lund; K Danø; E Appella; F Blasi
Journal:  EMBO J       Date:  1990-02       Impact factor: 11.598

View more
  51 in total

1.  Formation of polyomavirus-like particles with different VP1 molecules that bind the urokinase plasminogen activator receptor.

Authors:  Young C Shin; William R Folk
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

2.  Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion.

Authors:  Andrew S Gilder; Karra A Jones; Jingjing Hu; Lei Wang; Clark C Chen; Bob S Carter; Steven L Gonias
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

3.  A cleavage-resistant urokinase plasminogen activator receptor exhibits dysregulated cell-surface clearance.

Authors:  Evelyn C Nieves; Naveen Manchanda
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

4.  The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor.

Authors:  Nunzia Montuori; Katia Bifulco; Maria Vincenza Carriero; Claudio La Penna; Valeria Visconte; Daniela Alfano; Ada Pesapane; Francesca Wanda Rossi; Salvatore Salzano; Guido Rossi; Pia Ragno
Journal:  Cell Mol Life Sci       Date:  2010-10-24       Impact factor: 9.261

Review 5.  Primary focal and segmental glomerulosclerosis and soluble factor urokinase-type plasminogen activator receptor.

Authors:  Hernán Trimarchi
Journal:  World J Nephrol       Date:  2013-11-06

6.  Urokinase receptor orchestrates the plasminogen system in airway epithelial cell function.

Authors:  Ceri E Stewart; Ian Sayers
Journal:  Lung       Date:  2013-02-14       Impact factor: 2.584

7.  Targeting tumor cell invasion and dissemination in vivo by an aptamer that inhibits urokinase-type plasminogen activator through a novel multifunctional mechanism.

Authors:  Kenneth A Botkjaer; Elena I Deryugina; Daniel M Dupont; Henrik Gårdsvoll; Erin M Bekes; Cathrine K Thuesen; Zhuo Chen; Zhou Chen; Michael Ploug; James P Quigley; Peter A Andreasen
Journal:  Mol Cancer Res       Date:  2012-10-04       Impact factor: 5.852

8.  Mechanisms of kringle fragment of urokinase-induced vascular smooth muscle cell migration.

Authors:  Elisa Roztocil; Suzanne M Nicholl; Mark G Davies
Journal:  J Surg Res       Date:  2007-07       Impact factor: 2.192

9.  Urokinase-type plasminogen activator receptor is internalized by different mechanisms in polarized and nonpolarized Madin-Darby canine kidney epithelial cells.

Authors:  F Vilhardt; M Nielsen; K Sandvig; B van Deurs
Journal:  Mol Biol Cell       Date:  1999-01       Impact factor: 4.138

10.  Characterisation of urokinase plasminogen activator receptor variants in human airway and peripheral cells.

Authors:  Ceri E Stewart; Ian Sayers
Journal:  BMC Mol Biol       Date:  2009-07-28       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.